BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 1999

View Archived Issues

Sulfonylureas linked to increase in early mortality after angioplasty for acute MI

Read More

Antiallergic peptide compounds available for licensing from Yeda

Read More

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

Read More

Procyon receives Canadian patent for PSP94

Read More

Reanalysis of data attributes greater efficacy to Multikine

Read More

CuraGen and Roche reach drug discovery agreement

Read More

Cantab: 1998 year-end highlights

Read More

Small Molecule Therapeutics and Hybrigenics enter drug discovery collaboration

Read More

Venous leg ulcers unlikely to heal with compression therapy can be predicted at 4 weeks

Read More

U. of California reports new purine cyclin-dependent kinase inhibitors

Read More

Suntory synthesizes new inhibitors of PDE4 and TNF-alpha production

Read More

Aminoethylphenoxyacetic acids for urinary lithiasis in development at Kissei

Read More

New differentiation-inducing vitamin D compounds from Japanese lab

Read More

Lilly's new agents for lipid disorders act by increasing HDL cholesterol levels

Read More

Glaxo Wellcome seeks U.S. regulatory approval for combination asthma treatment

Read More

Hemosol product advances; company receives milestone payment from Fresenius

Read More

Boston Biomedica receives 510(k) clearance for Lyme IgM Western Blot test kit

Read More

Elastase inhibitor from Teijin looks promising in the treatment of respiratory disease

Read More

Suntory's neuroprotective compound SUN-N4057 is effective in rat models

Read More

Preclinical studies support BM-17.0744 as a potential treatment for metabolic syndrome

Read More

HMR-1883: not a classical antiarrhythmic agent

Read More

Studies show that ketolide compound ABT-773 is a promising new antimicrobial agent

Read More

Bristol-Myers Squibb drops antimigraine drug from the pipeline

Read More

In vitro data supporting antifungal efficacy of Nyotran presented at ECCMID

Read More

New antileukemia agents synthesized at Hughes Institute

Read More

More news from the ACS: DuPont synthesizes anti-HIV compounds derived from efavirenz

Read More

ACS highlights: Dainippon selects potent antitumor compound for development

Read More

NovoSeven approved in the U.S.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing